A Robust Control solution for Glycaemia Regulation of Type-1 Diabetes Mellitus

Louis Cassany; David Gucik-Derigny; Jerome Cieslak; David Henry; Roberto Franco; Alejandra Ferreira De Loza; Hector Rios; Loic Olcomendy; Antoine Pirog; Yannick Bornat; Sylvie Renaud; Bogdan Catargi

doi:10.23919/ECC54610.2021.9654888

A Robust Control solution for Glycaemia Regulation of Type-1 Diabetes Mellitus

Louis Cassany, David Gucik-Derigny, Jerome Cieslak, David Henry, Roberto Franco, Alejandra Ferreira De Loza, Hector Rios, Loic Olcomendy, Antoine Pirog, Yannick Bornat, Sylvie Renaud, Bogdan Catargi

Centro de Investigación y Desarrollo de Tecnología Digital (CITEDI)

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

6 Scopus citations

Abstract

The paper addresses the development of an artificial pancreas for the treatment of Type 1 Diabetes Mellitus, and more precisely the design of a control law for insulin delivery. As opposed to current existing solutions, the proposed approach is patient-independent, so it tackles the variability of the patients. Robust margins and worst-case performance are also established by means of the H∞/μ-analysis theory. The proposed solution is evaluated through the high-fidelity UVA/Padova simulator accepted by the US Food and Drug Administration as a substitute for pre-clinical testing of new treatment strategies.

Original language	English
Title of host publication	2021 European Control Conference, ECC 2021
Publisher	Institute of Electrical and Electronics Engineers Inc.
Pages	327-332
Number of pages	6
ISBN (Electronic)	9789463842365
DOIs	https://doi.org/10.23919/ECC54610.2021.9654888
State	Published - 2021
Event	2021 European Control Conference, ECC 2021 - Delft, Netherlands Duration: 29 Jun 2021 → 2 Jul 2021

Publication series

Name	2021 European Control Conference, ECC 2021

Conference

Conference	2021 European Control Conference, ECC 2021
Country/Territory	Netherlands
City	Delft
Period	29/06/21 → 2/07/21

Keywords

Artificial Pancreas
Biological systems
Robust PID
Type 1 Diabetes Mellitus

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.23919/ECC54610.2021.9654888

Cite this

Cassany, L., Gucik-Derigny, D., Cieslak, J., Henry, D., Franco, R., De Loza, A. F., Rios, H., Olcomendy, L., Pirog, A., Bornat, Y., Renaud, S., & Catargi, B. (2021). A Robust Control solution for Glycaemia Regulation of Type-1 Diabetes Mellitus. In 2021 European Control Conference, ECC 2021 (pp. 327-332). (2021 European Control Conference, ECC 2021). Institute of Electrical and Electronics Engineers Inc.. https://doi.org/10.23919/ECC54610.2021.9654888

@inproceedings{d1aa1c839dbb4d9d9b6a155449d68716,

title = "A Robust Control solution for Glycaemia Regulation of Type-1 Diabetes Mellitus",

abstract = "The paper addresses the development of an artificial pancreas for the treatment of Type 1 Diabetes Mellitus, and more precisely the design of a control law for insulin delivery. As opposed to current existing solutions, the proposed approach is patient-independent, so it tackles the variability of the patients. Robust margins and worst-case performance are also established by means of the H∞/μ-analysis theory. The proposed solution is evaluated through the high-fidelity UVA/Padova simulator accepted by the US Food and Drug Administration as a substitute for pre-clinical testing of new treatment strategies.",

keywords = "Artificial Pancreas, Biological systems, Robust PID, Type 1 Diabetes Mellitus",

author = "Louis Cassany and David Gucik-Derigny and Jerome Cieslak and David Henry and Roberto Franco and {De Loza}, {Alejandra Ferreira} and Hector Rios and Loic Olcomendy and Antoine Pirog and Yannick Bornat and Sylvie Renaud and Bogdan Catargi",

note = "Publisher Copyright: {\textcopyright} 2021 EUCA.; 2021 European Control Conference, ECC 2021 ; Conference date: 29-06-2021 Through 02-07-2021",

year = "2021",

doi = "10.23919/ECC54610.2021.9654888",

language = "Ingl{\'e}s",

series = "2021 European Control Conference, ECC 2021",

publisher = "Institute of Electrical and Electronics Engineers Inc.",

pages = "327--332",

booktitle = "2021 European Control Conference, ECC 2021",

address = "Estados Unidos",

}

Cassany, L, Gucik-Derigny, D, Cieslak, J, Henry, D, Franco, R, De Loza, AF, Rios, H, Olcomendy, L, Pirog, A, Bornat, Y, Renaud, S & Catargi, B 2021, A Robust Control solution for Glycaemia Regulation of Type-1 Diabetes Mellitus. in 2021 European Control Conference, ECC 2021. 2021 European Control Conference, ECC 2021, Institute of Electrical and Electronics Engineers Inc., pp. 327-332, 2021 European Control Conference, ECC 2021, Delft, Netherlands, 29/06/21. https://doi.org/10.23919/ECC54610.2021.9654888

A Robust Control solution for Glycaemia Regulation of Type-1 Diabetes Mellitus. / Cassany, Louis; Gucik-Derigny, David; Cieslak, Jerome et al.
2021 European Control Conference, ECC 2021. Institute of Electrical and Electronics Engineers Inc., 2021. p. 327-332 (2021 European Control Conference, ECC 2021).

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

TY - GEN

T1 - A Robust Control solution for Glycaemia Regulation of Type-1 Diabetes Mellitus

AU - Cassany, Louis

AU - Gucik-Derigny, David

AU - Cieslak, Jerome

AU - Henry, David

AU - Franco, Roberto

AU - De Loza, Alejandra Ferreira

AU - Rios, Hector

AU - Olcomendy, Loic

AU - Pirog, Antoine

AU - Bornat, Yannick

AU - Renaud, Sylvie

AU - Catargi, Bogdan

PY - 2021

Y1 - 2021

N2 - The paper addresses the development of an artificial pancreas for the treatment of Type 1 Diabetes Mellitus, and more precisely the design of a control law for insulin delivery. As opposed to current existing solutions, the proposed approach is patient-independent, so it tackles the variability of the patients. Robust margins and worst-case performance are also established by means of the H∞/μ-analysis theory. The proposed solution is evaluated through the high-fidelity UVA/Padova simulator accepted by the US Food and Drug Administration as a substitute for pre-clinical testing of new treatment strategies.

AB - The paper addresses the development of an artificial pancreas for the treatment of Type 1 Diabetes Mellitus, and more precisely the design of a control law for insulin delivery. As opposed to current existing solutions, the proposed approach is patient-independent, so it tackles the variability of the patients. Robust margins and worst-case performance are also established by means of the H∞/μ-analysis theory. The proposed solution is evaluated through the high-fidelity UVA/Padova simulator accepted by the US Food and Drug Administration as a substitute for pre-clinical testing of new treatment strategies.

KW - Artificial Pancreas

KW - Biological systems

KW - Robust PID

KW - Type 1 Diabetes Mellitus

UR - http://www.scopus.com/inward/record.url?scp=85120701034&partnerID=8YFLogxK

U2 - 10.23919/ECC54610.2021.9654888

DO - 10.23919/ECC54610.2021.9654888

M3 - Contribución a la conferencia

AN - SCOPUS:85120701034

T3 - 2021 European Control Conference, ECC 2021

SP - 327

EP - 332

BT - 2021 European Control Conference, ECC 2021

PB - Institute of Electrical and Electronics Engineers Inc.

T2 - 2021 European Control Conference, ECC 2021

Y2 - 29 June 2021 through 2 July 2021

ER -

A Robust Control solution for Glycaemia Regulation of Type-1 Diabetes Mellitus

Abstract

Publication series

Conference

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this